Intended Use

The SARS-CoV-2 IgM/IgG Duo Test is intended for the qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human serum, plasma and whole blood (fingerstick whole blood/venous whole blood).

Advantages

 

• Auxiliary discrimination recent acute infection or past infection: An increase in IgM antibody indicates a recent acute infection, and an increase in IgG antibody indicates a past infection
• Excellent Performance: Sensitivity 96.77%, Specificity 98.39%